Skip to main content
. 2022 Dec 9;12(12):2041. doi: 10.3390/jpm12122041

Figure 2.

Figure 2

Recurrence-free survival (RFS) curves of grouped intrahepatic cholangiocarcinoma patients based on (A) AFP, (B) PIVKA-II, (C) CEA, and (D) CA19-9.